In the News

MSK has joined with 68 of the nation’s top cancer centers in issuing a statement urging increased HPV vaccination for the prevention of cancer. This statement, signed by MSK Physician-in-Chief and Chief Medical Officer José Baslega, MD, PhD, and colleagues at NCI-designated cancer centers across the country, calls upon the nation’s physicians, parents, and young adults to take advantage of this rare opportunity to prevent many types of cancer. MSK head and neck and gynecologic cancer experts are available to discuss the importance of the HPV vaccine and risks of HPV-related cancers. Please email [email protected] to arrange an interview.

MSK joins other leading cancer institutions in calling for increased vaccination to protect against human papillomavirus, which causes many forms of cancer.

MSK medical oncologist David Straus is looking for less-intensive treatments for Hodgkin lymphoma, a type of blood cancer most commonly found in young adults.

An innovative collaboration between basic scientists and clinical researchers has led to a promising new drug for AML.

Scientists are using a molecule from the immune system to combat this serious complication in a new way.

During his State of the Union address, President Obama proposed a “moonshot” to cure cancer. Following that, MSK physicians attended a roundtable discussion at the World Economic Forum in Davos-Klosters, Switzerland to discuss progress on what a cure might look like.

MSK researchers are rethinking the relationship between metabolism and cancer, and finding insights in some unexpected places. Your beer glass, for example.

Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule an interview with a member of MSK’s breast cancer leadership team, please contact Nicole McNamara at [email protected].

The new Fiona and Stanley Druckenmiller Center for Lung Cancer Research brings together MSK physicians and scientists in an intensive, multidisciplinary effort against the number-one cause of death from cancer in the nation.

A multi-institutional effort led by MSK’s Charles Sawyers is seeking to interpret information about the genetic causes of cancer.